Doptelet(R) (avatrombopag) approved in the EU for treatment of ITP

STOCKHOLM, Jan. 20, 2021 -- (Healthcare Sales & Marketing Network) -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) today announces that the European Commission (EC) has approved an extension of the indication for Doptelet (avatrombopag) to includ... Biopharmaceuticals, Regulatory Swedish Orphan Biovitrum, Sobi , Doptelet, avatrombopag
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news